*Meriva® highly bioavailable curcumin phytosome
CurcumaSorb provides the patented Meriva® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva® per day provided significant benefit in joint comfort, mobility and quality of life.*
CurcumaSorb delivers highly bioavailable curcumin, providing maximal support for musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.
Meriva® is a trademark of Indena S.p.A.
Phytosome More Bioavailable is a trademark of Indena S.p.A.